Kennedy Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200,980
Closed -$4.9M 662
2021
Q1
$4.9M Sell
200,980
-11,105
-5% -$251K 0.1% 375
2020
Q4
$4.12M Buy
+212,085
New +$3.9M 0.09% 391
2017
Q4
Sell
-66,110
Closed -$2.45M 766
2017
Q3
$2.45M Sell
66,110
-32,894
-33% -$1.24M 0.04% 588
2017
Q2
$3.67M Buy
99,004
+1,355
+1% +$44.2K 0.07% 482
2017
Q1
$2.74M Sell
97,649
-3,884
-4% -$110K 0.05% 551
2016
Q4
$2.98M Sell
101,533
-620
-0.6% -$16.9K 0.05% 531
2016
Q3
$2.78M Buy
+102,153
New +$2.31M 0.05% 510

Other funds holding PAHC

Kennedy Capital Management's PAHC Position: Q2 2021 in Review

Kennedy Capital Management sold out of Phibro Animal Health (PAHC) in Q2 2021, closing a stake of 200,980 shares — an estimated $4.9M sold.

Kennedy Capital Management first reported a position in PAHC in Q3 2016 and held it in 7 quarters. The position peaked at $4.9M in Q1 2021. 146 funds tracked by Wall St. Rank hold PAHC as of Q2 2021.

  • Kennedy Capital Management reported no remaining Phibro Animal Health position as of Q2 2021 after selling out during the quarter.
  • Kennedy Capital Management sold 200,980 Phibro Animal Health shares in Q2 2021, an estimated $4.9M.
  • Kennedy Capital Management first reported a position in Phibro Animal Health in Q3 2016 and held it in 7 quarters.
  • Kennedy Capital Management's Phibro Animal Health position peaked at $4.9M in Q1 2021.
  • 146 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2021.

Based on Kennedy Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.